nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—Coma hepatic—Capecitabine—esophageal cancer	0.0158	0.237	CcSEcCtD
Fluoxymesterone—Amcinonide—ANXA1—esophageal cancer	0.0107	0.209	CrCbGaD
Fluoxymesterone—Azoospermia—Cisplatin—esophageal cancer	0.00999	0.15	CcSEcCtD
Fluoxymesterone—SHBG—neck—esophageal cancer	0.00875	0.119	CbGeAlD
Fluoxymesterone—Oligospermia—Methotrexate—esophageal cancer	0.00704	0.105	CcSEcCtD
Fluoxymesterone—ESR1—neck—esophageal cancer	0.00617	0.0841	CbGeAlD
Fluoxymesterone—Azoospermia—Methotrexate—esophageal cancer	0.00548	0.082	CcSEcCtD
Fluoxymesterone—NR3C1—neck—esophageal cancer	0.00455	0.062	CbGeAlD
Fluoxymesterone—Hydrocortisone—ANXA1—esophageal cancer	0.0045	0.0881	CrCbGaD
Fluoxymesterone—Testolactone—CYP19A1—esophageal cancer	0.00429	0.084	CrCbGaD
Fluoxymesterone—AR—epithelium—esophageal cancer	0.00427	0.0583	CbGeAlD
Fluoxymesterone—AR—bronchus—esophageal cancer	0.00421	0.0574	CbGeAlD
Fluoxymesterone—ESR1—epithelium—esophageal cancer	0.0042	0.0572	CbGeAlD
Fluoxymesterone—AR—smooth muscle tissue—esophageal cancer	0.00412	0.0562	CbGeAlD
Fluoxymesterone—ESR1—smooth muscle tissue—esophageal cancer	0.00404	0.0551	CbGeAlD
Fluoxymesterone—Hirsutism—Capecitabine—esophageal cancer	0.00341	0.0511	CcSEcCtD
Fluoxymesterone—Dexamethasone—ANXA1—esophageal cancer	0.00335	0.0656	CrCbGaD
Fluoxymesterone—AR—digestive system—esophageal cancer	0.00325	0.0443	CbGeAlD
Fluoxymesterone—ESR1—digestive system—esophageal cancer	0.00319	0.0435	CbGeAlD
Fluoxymesterone—NR3C1—epithelium—esophageal cancer	0.0031	0.0422	CbGeAlD
Fluoxymesterone—NR3C1—bronchus—esophageal cancer	0.00305	0.0416	CbGeAlD
Fluoxymesterone—NR3C1—smooth muscle tissue—esophageal cancer	0.00298	0.0407	CbGeAlD
Fluoxymesterone—NR3C1—trachea—esophageal cancer	0.00274	0.0373	CbGeAlD
Fluoxymesterone—AR—lung—esophageal cancer	0.00272	0.037	CbGeAlD
Fluoxymesterone—ESR1—lung—esophageal cancer	0.00267	0.0364	CbGeAlD
Fluoxymesterone—Coagulopathy—Capecitabine—esophageal cancer	0.00255	0.0381	CcSEcCtD
Fluoxymesterone—NR3C1—digestive system—esophageal cancer	0.00236	0.0321	CbGeAlD
Fluoxymesterone—Spironolactone—ABCC2—esophageal cancer	0.0021	0.0412	CrCbGaD
Fluoxymesterone—Danazol—CYP19A1—esophageal cancer	0.00206	0.0404	CrCbGaD
Fluoxymesterone—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00202	0.0302	CcSEcCtD
Fluoxymesterone—NR3C1—lung—esophageal cancer	0.00197	0.0268	CbGeAlD
Fluoxymesterone—AR—lymph node—esophageal cancer	0.00186	0.0253	CbGeAlD
Fluoxymesterone—ESR1—lymph node—esophageal cancer	0.00182	0.0249	CbGeAlD
Fluoxymesterone—Prednisolone—CYP2A6—esophageal cancer	0.0018	0.0353	CrCbGaD
Fluoxymesterone—Methyltestosterone—CYP19A1—esophageal cancer	0.00174	0.0342	CrCbGaD
Fluoxymesterone—Betamethasone—CYP19A1—esophageal cancer	0.00168	0.033	CrCbGaD
Fluoxymesterone—Dexamethasone—NOS2—esophageal cancer	0.00157	0.0307	CrCbGaD
Fluoxymesterone—Libido decreased—Capecitabine—esophageal cancer	0.00155	0.0232	CcSEcCtD
Fluoxymesterone—Progesterone—CYP1B1—esophageal cancer	0.00146	0.0286	CrCbGaD
Fluoxymesterone—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00143	0.0214	CcSEcCtD
Fluoxymesterone—Testosterone—CYP1B1—esophageal cancer	0.00138	0.027	CrCbGaD
Fluoxymesterone—NR3C1—lymph node—esophageal cancer	0.00135	0.0183	CbGeAlD
Fluoxymesterone—Dexamethasone—CYP1B1—esophageal cancer	0.00133	0.0261	CrCbGaD
Fluoxymesterone—Gynaecomastia—Methotrexate—esophageal cancer	0.00132	0.0198	CcSEcCtD
Fluoxymesterone—Megestrol acetate—ABCB1—esophageal cancer	0.00124	0.0244	CrCbGaD
Fluoxymesterone—Alopecia—Cisplatin—esophageal cancer	0.00119	0.0179	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CYP19A1—esophageal cancer	0.00117	0.00145	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NR1I2—esophageal cancer	0.00116	0.00143	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.00114	0.00141	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—MYC—esophageal cancer	0.00113	0.0014	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—CREBBP—esophageal cancer	0.00113	0.00139	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—XIAP—esophageal cancer	0.00113	0.00139	CbGpPWpGaD
Fluoxymesterone—Progesterone—CYP2A6—esophageal cancer	0.00112	0.022	CrCbGaD
Fluoxymesterone—PRLR—Immune System—ABL1—esophageal cancer	0.00112	0.00139	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—PIK3CA—esophageal cancer	0.00112	0.00139	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—MYC—esophageal cancer	0.00111	0.00137	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—esophageal cancer	0.00111	0.00137	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CDKN2A—esophageal cancer	0.00111	0.00137	CbGpPWpGaD
Fluoxymesterone—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00111	0.0166	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.0011	0.00136	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	0.0011	0.00136	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—esophageal cancer	0.0011	0.00136	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—esophageal cancer	0.00109	0.00135	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CDKN2A—esophageal cancer	0.00109	0.00135	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.00109	0.00135	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TGFBR2—esophageal cancer	0.00108	0.00134	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—esophageal cancer	0.00108	0.00133	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—CCND1—esophageal cancer	0.00108	0.00133	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—NOS3—esophageal cancer	0.00107	0.00133	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CTNNA1—esophageal cancer	0.00107	0.00132	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—EP300—esophageal cancer	0.00106	0.00131	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.00106	0.00131	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CXCL2—esophageal cancer	0.00106	0.00131	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—ABL1—esophageal cancer	0.00106	0.00131	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.00105	0.0013	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—esophageal cancer	0.00105	0.0013	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.00104	0.00129	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—ABCC2—esophageal cancer	0.00104	0.0204	CrCbGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.00103	0.00128	CbGpPWpGaD
Fluoxymesterone—NR3C1—Circadian Clock—EP300—esophageal cancer	0.00103	0.00127	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.00103	0.00127	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—CYP2A6—esophageal cancer	0.00103	0.0201	CrCbGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—SMAD4—esophageal cancer	0.00103	0.00127	CbGpPWpGaD
Fluoxymesterone—Testosterone—CYP19A1—esophageal cancer	0.00101	0.0198	CrCbGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—esophageal cancer	0.00101	0.00125	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—esophageal cancer	0.00101	0.00124	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CCND1—esophageal cancer	0.001	0.00124	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—ERBB2—esophageal cancer	0.001	0.00124	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Capecitabine—esophageal cancer	0.001	0.015	CcSEcCtD
Fluoxymesterone—Anxiety—Cisplatin—esophageal cancer	0.000998	0.0149	CcSEcCtD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—esophageal cancer	0.000997	0.00123	CbGpPWpGaD
Fluoxymesterone—Haemorrhage—Capecitabine—esophageal cancer	0.000996	0.0149	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—PSME1—esophageal cancer	0.00099	0.00122	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PSME2—esophageal cancer	0.00099	0.00122	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—EP300—esophageal cancer	0.00099	0.00122	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ANXA1—esophageal cancer	0.000985	0.00122	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—esophageal cancer	0.000979	0.00121	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—CYP19A1—esophageal cancer	0.000979	0.0192	CrCbGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CDKN1A—esophageal cancer	0.000972	0.0012	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—BAX—esophageal cancer	0.00097	0.0012	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Cisplatin—esophageal cancer	0.00096	0.0144	CcSEcCtD
Fluoxymesterone—ESR1—Regulation of Telomerase—CCND1—esophageal cancer	0.00096	0.00119	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SST—esophageal cancer	0.000958	0.00119	CbGpPWpGaD
Fluoxymesterone—Triamcinolone—PTGS2—esophageal cancer	0.000945	0.0185	CrCbGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CCND1—esophageal cancer	0.000938	0.00116	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOTCH3—esophageal cancer	0.000934	0.00115	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GHRL—esophageal cancer	0.000934	0.00115	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—HIF1A—esophageal cancer	0.000931	0.00115	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—EP300—esophageal cancer	0.000927	0.00115	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—EP300—esophageal cancer	0.000925	0.00114	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CCND1—esophageal cancer	0.000923	0.00114	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FBXW7—esophageal cancer	0.000919	0.00114	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—TP53—esophageal cancer	0.000912	0.00113	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CASP8—esophageal cancer	0.000893	0.0011	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NR1I2—esophageal cancer	0.000892	0.0011	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—CCND1—esophageal cancer	0.000887	0.0011	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—RB1—esophageal cancer	0.000886	0.0011	CbGpPWpGaD
Fluoxymesterone—Alopecia—Capecitabine—esophageal cancer	0.00088	0.0132	CcSEcCtD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NR1I2—esophageal cancer	0.000879	0.00109	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—esophageal cancer	0.000877	0.00108	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.000877	0.00108	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—esophageal cancer	0.000869	0.00107	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000867	0.00107	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—EP300—esophageal cancer	0.000863	0.00107	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Cisplatin—esophageal cancer	0.000862	0.0129	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—TLR4—esophageal cancer	0.000851	0.00105	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—EP300—esophageal cancer	0.00085	0.00105	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	0.000849	0.00105	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.000849	0.00105	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOTCH2—esophageal cancer	0.000838	0.00104	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—MYC—esophageal cancer	0.000808	0.000999	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—esophageal cancer	0.000807	0.000998	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.000805	0.000995	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.000804	0.000994	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—esophageal cancer	0.000795	0.000983	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—EGFR—esophageal cancer	0.000788	0.000974	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—esophageal cancer	0.000787	0.000973	CbGpPWpGaD
Fluoxymesterone—Betamethasone—PTGS2—esophageal cancer	0.000774	0.0152	CrCbGaD
Fluoxymesterone—Spironolactone—ABCB1—esophageal cancer	0.000774	0.0151	CrCbGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—MYC—esophageal cancer	0.00077	0.000952	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—esophageal cancer	0.000768	0.00095	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—BCL2—esophageal cancer	0.000767	0.000948	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—RB1—esophageal cancer	0.000758	0.000937	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—esophageal cancer	0.000756	0.000935	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—EGFR—esophageal cancer	0.000753	0.000931	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MYC—esophageal cancer	0.000752	0.00093	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—EP300—esophageal cancer	0.000749	0.000926	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Methotrexate—esophageal cancer	0.000745	0.0112	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—TGFBR2—esophageal cancer	0.000743	0.000919	CbGpPWpGaD
Fluoxymesterone—Haemorrhage—Methotrexate—esophageal cancer	0.000741	0.0111	CcSEcCtD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MYC—esophageal cancer	0.000741	0.000916	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	0.00074	0.000915	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	0.000737	0.000911	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SMG6—esophageal cancer	0.000736	0.00091	CbGpPWpGaD
Fluoxymesterone—Anxiety—Capecitabine—esophageal cancer	0.000735	0.011	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—CASP8—esophageal cancer	0.00073	0.000903	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000727	0.000899	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CREBBP—esophageal cancer	0.000727	0.000899	CbGpPWpGaD
Fluoxymesterone—Norethindrone—ABCB1—esophageal cancer	0.000718	0.0141	CrCbGaD
Fluoxymesterone—Hypersensitivity—Cisplatin—esophageal cancer	0.000707	0.0106	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—SMAD4—esophageal cancer	0.000703	0.00087	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CASP8—esophageal cancer	0.000688	0.000851	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—RB1—esophageal cancer	0.000683	0.000844	CbGpPWpGaD
Fluoxymesterone—Prednisolone—ABCB1—esophageal cancer	0.000672	0.0132	CrCbGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—esophageal cancer	0.000669	0.000827	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—esophageal cancer	0.000659	0.000815	CbGpPWpGaD
Fluoxymesterone—Betamethasone—ABCB1—esophageal cancer	0.000658	0.0129	CrCbGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CCND1—esophageal cancer	0.000658	0.000814	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000657	0.000813	CbGpPWpGaD
Fluoxymesterone—Alopecia—Methotrexate—esophageal cancer	0.000655	0.00981	CcSEcCtD
Fluoxymesterone—AR—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000652	0.000807	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.000635	0.000785	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Capecitabine—esophageal cancer	0.000635	0.00951	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—BCL2—esophageal cancer	0.000627	0.000775	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GDI2—esophageal cancer	0.000625	0.000773	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—esophageal cancer	0.000618	0.000764	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.000617	0.000763	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ERBB2—esophageal cancer	0.000609	0.000753	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—esophageal cancer	0.000608	0.000752	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EP300—esophageal cancer	0.000606	0.000749	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.000603	0.000746	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—BCL2—esophageal cancer	0.000591	0.00073	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.00059	0.00073	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HIF1A—esophageal cancer	0.000576	0.000712	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—ERBB2—esophageal cancer	0.000571	0.000706	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	0.00057	0.000705	CbGpPWpGaD
Fluoxymesterone—Nausea—Cisplatin—esophageal cancer	0.00057	0.00853	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	0.000568	0.000702	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SMG6—esophageal cancer	0.000567	0.000701	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.00056	0.000693	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SMG6—esophageal cancer	0.000558	0.00069	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NR1I2—esophageal cancer	0.000558	0.000689	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000552	0.000682	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KDR—esophageal cancer	0.00055	0.000681	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000548	0.000677	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.000545	0.000674	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—CDKN1A—esophageal cancer	0.000544	0.000673	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—esophageal cancer	0.000536	0.000663	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MYC—esophageal cancer	0.000528	0.000653	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.000528	0.000652	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Methotrexate—esophageal cancer	0.000527	0.00788	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Capecitabine—esophageal cancer	0.000521	0.0078	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—CDKN1A—esophageal cancer	0.00052	0.000644	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOTCH1—esophageal cancer	0.000519	0.000641	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EGFR—esophageal cancer	0.000516	0.000638	CbGpPWpGaD
Fluoxymesterone—Hydrocortisone—ABCB1—esophageal cancer	0.000514	0.0101	CrCbGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CCND1—esophageal cancer	0.000507	0.000627	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000502	0.000621	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.000502	0.000621	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EP300—esophageal cancer	0.000495	0.000612	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000495	0.000612	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.000489	0.000605	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—CDKN1A—esophageal cancer	0.000488	0.000603	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—HIST1H2BM—esophageal cancer	0.000478	0.000591	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.000475	0.000588	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Methotrexate—esophageal cancer	0.000473	0.00708	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—CREBBP—esophageal cancer	0.00047	0.000581	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EP300—esophageal cancer	0.000467	0.000577	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.000465	0.000575	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KMT2D—esophageal cancer	0.000452	0.000559	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—PTGS2—esophageal cancer	0.00045	0.00882	CrCbGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000448	0.000554	CbGpPWpGaD
Fluoxymesterone—Headache—Capecitabine—esophageal cancer	0.000443	0.00663	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.000437	0.000541	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—esophageal cancer	0.000433	0.000536	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NR1I2—esophageal cancer	0.00043	0.000531	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.000428	0.000529	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NR1I2—esophageal cancer	0.000423	0.000523	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EGFR—esophageal cancer	0.000422	0.000522	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000422	0.000522	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOS3—esophageal cancer	0.000421	0.00052	CbGpPWpGaD
Fluoxymesterone—Nausea—Capecitabine—esophageal cancer	0.00042	0.00629	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.00042	0.000519	CbGpPWpGaD
Fluoxymesterone—Progesterone—ABCB1—esophageal cancer	0.000419	0.0082	CrCbGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000416	0.000514	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MYC—esophageal cancer	0.000407	0.000503	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.000406	0.000502	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000404	0.000499	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADCYAP1—esophageal cancer	0.000403	0.000498	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—esophageal cancer	0.000398	0.000492	CbGpPWpGaD
Fluoxymesterone—Testosterone—ABCB1—esophageal cancer	0.000396	0.00775	CrCbGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—EGFR—esophageal cancer	0.000396	0.000489	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ERBB2—esophageal cancer	0.000394	0.000487	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Methotrexate—esophageal cancer	0.000388	0.00581	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.000387	0.000478	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—ABCB1—esophageal cancer	0.000383	0.0075	CrCbGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.000371	0.000459	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PSME2—esophageal cancer	0.000371	0.000459	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PSME1—esophageal cancer	0.000371	0.000459	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—HIST1H2BM—esophageal cancer	0.000369	0.000456	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—WWOX—esophageal cancer	0.000369	0.000456	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PIK3CA—esophageal cancer	0.000366	0.000453	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000366	0.000453	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—HIST1H2BM—esophageal cancer	0.000363	0.000449	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.000359	0.000444	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FKBP1A—esophageal cancer	0.000351	0.000433	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NOTCH3—esophageal cancer	0.00035	0.000433	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCND1—esophageal cancer	0.000348	0.00043	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3CA—esophageal cancer	0.000343	0.000425	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—WIF1—esophageal cancer	0.000343	0.000424	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.000337	0.000417	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN1A—esophageal cancer	0.000337	0.000416	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—esophageal cancer	0.000334	0.000413	CbGpPWpGaD
Fluoxymesterone—Headache—Methotrexate—esophageal cancer	0.00033	0.00494	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.00033	0.000407	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EP300—esophageal cancer	0.00032	0.000396	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000316	0.000391	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NOTCH2—esophageal cancer	0.000314	0.000388	CbGpPWpGaD
Fluoxymesterone—Nausea—Methotrexate—esophageal cancer	0.000313	0.00468	CcSEcCtD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000311	0.000385	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000306	0.000379	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PFN1—esophageal cancer	0.000296	0.000366	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.000286	0.000354	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PSME1—esophageal cancer	0.000286	0.000353	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PSME2—esophageal cancer	0.000286	0.000353	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000282	0.000349	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PSME1—esophageal cancer	0.000282	0.000348	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PSME2—esophageal cancer	0.000282	0.000348	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MYC—esophageal cancer	0.000279	0.000345	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000278	0.000343	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.000277	0.000342	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EGFR—esophageal cancer	0.000273	0.000337	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NOTCH3—esophageal cancer	0.00027	0.000334	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NOTCH3—esophageal cancer	0.000266	0.000328	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ELMO1—esophageal cancer	0.000266	0.000328	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SMAD4—esophageal cancer	0.000264	0.000326	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKAP13—esophageal cancer	0.00026	0.000321	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NOTCH2—esophageal cancer	0.000242	0.000299	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.00024	0.000296	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NOTCH2—esophageal cancer	0.000238	0.000295	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PDE4D—esophageal cancer	0.000237	0.000294	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CA—esophageal cancer	0.000237	0.000293	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—esophageal cancer	0.000229	0.000283	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GNG7—esophageal cancer	0.000226	0.000279	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—MYC—esophageal cancer	0.000217	0.000269	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—XIAP—esophageal cancer	0.000212	0.000262	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SMAD4—esophageal cancer	0.000203	0.000251	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CTNNA1—esophageal cancer	0.0002	0.000247	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SMAD4—esophageal cancer	0.0002	0.000247	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCL2—esophageal cancer	0.000199	0.000246	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NOTCH1—esophageal cancer	0.000194	0.00024	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PSME2—esophageal cancer	0.000186	0.00023	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PSME1—esophageal cancer	0.000186	0.00023	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ANXA1—esophageal cancer	0.000185	0.000229	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SST—esophageal cancer	0.00018	0.000223	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—CREBBP—esophageal cancer	0.000176	0.000218	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GHRL—esophageal cancer	0.000175	0.000217	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOTCH3—esophageal cancer	0.000175	0.000217	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FBXW7—esophageal cancer	0.000173	0.000213	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MYC—esophageal cancer	0.000167	0.000207	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MYC—esophageal cancer	0.000165	0.000204	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOTCH2—esophageal cancer	0.000157	0.000194	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NOTCH1—esophageal cancer	0.00015	0.000185	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NOTCH1—esophageal cancer	0.000147	0.000182	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFBR2—esophageal cancer	0.00014	0.000173	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—CREBBP—esophageal cancer	0.000136	0.000168	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—CREBBP—esophageal cancer	0.000134	0.000165	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SMAD4—esophageal cancer	0.000132	0.000163	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HIF1A—esophageal cancer	0.000108	0.000134	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MYC—esophageal cancer	0.000105	0.000129	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KDR—esophageal cancer	0.000103	0.000128	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOTCH1—esophageal cancer	9.74e-05	0.00012	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CREBBP—esophageal cancer	8.83e-05	0.000109	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MYC—esophageal cancer	8.06e-05	9.96e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MYC—esophageal cancer	7.94e-05	9.81e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOS3—esophageal cancer	7.9e-05	9.77e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ERBB2—esophageal cancer	7.39e-05	9.14e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCND1—esophageal cancer	6.53e-05	8.08e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN1A—esophageal cancer	6.32e-05	7.81e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EP300—esophageal cancer	6.01e-05	7.43e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MYC—esophageal cancer	5.24e-05	6.48e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGFR—esophageal cancer	5.12e-05	6.34e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CA—esophageal cancer	4.45e-05	5.5e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—esophageal cancer	4.3e-05	5.32e-05	CbGpPWpGaD
